Direct comparison of the growth inhibitory effectiveness of IXA vs. BTZ in leukemic cells lines showed that BTZ was ~10-fold more potent than IXA, being consistent with data for MM cell line studies [29]. Here, CASC3 is linked to Miyoshi myopathy.